Cited by 65Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related DiseasesDelphi Technique in Research

Multicenter Delphi Exercise to Identify Important Key Items for Classifying Systemic Lupus Erythematosus

Open access
Schmajuk, Gabriela, Hoyer, Bimba F., Aringer, Martin, Johnson, Sindhu R., Daikh, David I., Dörner, Thomas, the SLE classification criteria steering committee and the international SLE expert panel of the initiative·2018·Arthritis Care & Research

Abstract

Objective: The American College of Rheumatology and the European League Against Rheumatism embarked on a project to reevaluate classification criteria for systemic lupus erythematosus ( SLE ). The first phase of the classification project involved generation of a broad set of items potentially useful for classification of SLE and their selection for use in a subsequent forced‐choice decision analysis. Methods: A large international group of expert lupus clinicians was invited to participate in a 2‐step process to generate, rate, and select items based on their importance in diagnosing early and established SLE , via a web‐based survey. Results: A total of 135 and 147 experts were invited to participate in the item‐generation and item‐reduction process, respectively. Of 145 items generated, item reduction resulted in 40 candidate items moving forward to the next phase. Key features for classifying both early and established SLE included characteristic autoantibodies, specific renal features, and skin manifestations. A small majority (51%) stated that 1 organ system would be sufficient for classifying SLE , but that additional typical laboratory features (antinuclear antibody, anti–double‐stranded DNA ) would be required. Notably, 85% of the expert group would positively classify SLE if renal pathology alone showed lupus nephritis. Conclusion: The Delphi exercise resulted in a set of 40 candidate criteria for the classification of SLE for subsequent assessment. This study comprised the largest panel ever involved in the development of SLE classification criteria, providing a broadly representative view of the current approach to classification of SLE .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr.23503

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Little information is given on the basis for inclusion of the anti-dsDNA test in the criteria, suggesting that this item is largely based on expert opinion.

    “Little information is given on the basis for inclusion of the anti-dsDNA test in the criteria, suggesting that this item is largely based on expert opinion [24,25].”

    From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [25]

    The Results (Thematic analysis; page unavailable) report that 99% of experts considered anti-dsDNA and anti-Sm the most typical serologic findings of SLE, supporting an expert-opinion basis for considering anti-dsDNA. But the Methods (Item generation; page unavailable) also describe a literature review and inclusion of existing criteria, while the Discussion says this Delphi exercise produced candidate items, not final criteria. The paper therefore does not establish that inclusion in the final criteria was largely based on expert opinion. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Positive anti-dsDNA antibodies received the highest Delphi score (8.94) which determined the highest score (6 points) in the weighted scoring of the disease.

    “In fact, positive anti-dsDNA antibodies received the highest Delphi score (8.94) which determined the highest score (6 points) in the weighted scoring of the disease.”

    From Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus (2022) · cites this paper as [25]

    The Results (Thematic analysis; page unavailable) say 99% of experts considered anti-dsDNA and anti-Sm antibodies the most typical serologic findings of SLE. The Methods describe Delphi appropriateness ratings, but the passages in our copy do not substantiate an anti-dsDNA score of 8.94, a six-point weighted score, or the claim that the former determined the latter. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [7]Aringer M Dörner T Leuchten N Johnson SR Toward new criteria for systemic lupus erythematosus-a standpoint Lupus 2016 8 805 11 PMID: 27252256 27252256

Cited by

Sorted by citations

Authors
Schmajuk, G., Hoyer, B. F., Aringer, M., Johnson, S. R., Daikh, D. I., Dörner, T., & the SLE classification criteria steering committee and the international SLE expert panel of the initiative
Affiliations
  • San Francisco VA Medical Center (US)
  • German Rheumatism Research Centre (DE)
  • University Hospital Carl Gustav Carus (DE)
  • Mount Sinai Hospital (CA)
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2018-09-11
Volume
70
Issue
10
Pages
1488-1494
ISSN
  • 0893-7524 (ISSN-L)
  • 2151-464X
  • 2151-4658
OpenAlex
W2779862955
Cited by
65
References
21
Citations by year
2026: 5 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 12 · 2018: 3 · 2017: 1
FWCI
6.21
Type
journal article
Language
en
Open access
Locations
  • Arthritis Care & Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR063770)
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Systemic Sclerosis and Related Diseases
  • Social Sciences › Sociology and Political Science › Delphi Technique in Research
Keywords
systemic lupus erythematosus, classification criteria, item generation, item reduction, expert consensus, autoantibodies, antinuclear antibodies, anti-dsDNA antibodies, lupus nephritis, renal manifestations, cutaneous manifestations, organ involvement
MeSH terms
Antibodies, Antinuclear, Delphi Technique, Humans, Kidney, Lupus Erythematosus, Systemic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review